This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Patients Overwhelmingly Prefer Digital Check-In To Paper Clipboard

ATLANTA, Jan. 17, 2013 /PRNewswire/ -- According to a recent survey conducted by Digital Assent, a healthcare media and marketing company headquartered in Atlanta, patient acceptance of using a tablet computer at the doctor's office is very high.  A resounding 94 percent of patients reported that they enjoyed using Digital Assent's PatientPad® tablet computer during their office visit and 84 percent of respondents reported that checking in on the PatientPad was "better than a clipboard." 

Patients also found the experience noteworthy, with one third of respondents reporting that they discussed their PatientPad experience with family and friends after leaving the doctor's office.  The internally-conducted survey included responses from 85 patients who used the company's PatientPad tablet solution to check-in for their appointment.  The respondents spanned 11 medical practices, and the responding patients represented a 17 percent response rate for the survey. 

Digital Assent CEO Andrew Ibbotson commented, "Consumer self-service options have been growing rapidly in other areas of life, so the positive feedback from PatientPad users in this survey is not surprising.  Patients of all ages are coming to expect the privacy and convenience of self-service tablet technology, like the PatientPad, when they visit their healthcare provider." 

Once the check-in process is complete, the PatientPad also provides patients with an opportunity to explore educational content and product advertisements specifically tailored to the medical office that they're visiting.  Digital Assent's survey was presented to patients between 24 and 72 hours after they used the PatientPad.  

In addition to patient acceptance of the technology, the survey measured the effectiveness of advertising delivered to patients on the PatientPad tablet while waiting to see their healthcare provider.  When asked about specific advertising content that was presented to them, survey responders revealed:

  • Thirty (30) percent of respondents reported taking action as a direct result of advertising they saw on the PatientPad
  • Twenty-two (22) percent had unaided recall of branded content presented to them on the PatientPad
  • Sixty-one (61) percent correctly recognized and identified branded content presented to them on the PatientPad

"From its conception, PatientPad seemed like it could realize every marketer's dream of consistently engaging the right person, with the right message, in the right location, at the right time," stated Whit Lanier, Digital Assent's vice president of marketing and advertising operations.  Lanier continued, "These survey results are even better than we expected, and provide a strong argument that the PatientPad might be the perfect vehicle for healthcare consumer marketing." 

Since concluding the survey, PatientPad has made software and hardware enhancements which have further increased overall levels of patient satisfaction and patient engagement.  PatientPad also continues to add new applications which deliver measurable value to the patient and the practice, including real-time healthcare financing and redeemable point-of-service coupons. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs